Immunitas Therapeutics
1 clinical trials · Sponsor
◉ Watch Immunitas Therapeutics
| Record | Firm | Date |
|---|---|---|
| Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas (NCT05565417) | Immunitas Therapeutics | 2022-11-28 |
Track Immunitas Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.